Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements
- 29 January 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (5), 1203-1204
- https://doi.org/10.1182/blood-2008-09-178848
Abstract
To the editor Greiner et al[1][1] described a positive association between elevated leukemia-associated antigen (LAA) expression (RHAMM, G250/CA9, and PRAME) and survival in 116 acute myeloid leukemia (AML) patients by microarray. We have analyzed 312 presentation AML samples using 199 133A chipsKeywords
This publication has 8 references indexed in Scilit:
- Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia CellsClinical Cancer Research, 2008
- SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patientsBritish Journal of Haematology, 2007
- Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approachesBlood, 2006
- Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemiaBiochemical and Biophysical Research Communications, 2005
- Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stabilityBiochemical and Biophysical Research Communications, 2005
- The cancer‐related protein SSX2 interacts with the human homologue of a Ras‐like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IPGenes, Chromosomes and Cancer, 2002
- Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemiaBlood, 2001
- Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM VariantsBlood, 1999